# Pseudomonas aeruginosa gene expression changes during established biofilm infection in a cystic fibrosis lung model

**Authors:** Niamh E. Harrington, Freya Allen, Ramón Garcia Maset, Freya Harrison

PMC · DOI: 10.1099/mic.0.001678 · 2026-03-05

## TL;DR

This study examines how Pseudomonas aeruginosa changes its gene activity during a 7-day biofilm infection in a model of the cystic fibrosis lung.

## Contribution

The study provides new insights into gene expression changes in P. aeruginosa during established chronic biofilm infection in a clinically relevant model.

## Key findings

- The EVPL model supports P. aeruginosa biofilm growth and increased antibiotic tolerance for at least 7 days.
- Significant upregulation of sulfur metabolism genes was observed in the biofilm.
- Antimicrobial resistance gene expression did not change significantly over time.

## Abstract

The opportunistic pathogen Pseudomonas aeruginosa forms biofilm infections in the lungs of people with the genetic condition cystic fibrosis (CF) that can persist for decades. There are numerous P. aeruginosa lifestyle changes associated with chronic biofilm infection that are cued by the CF lung environment. These include a loss of virulence, metabolic changes and increased antimicrobial tolerance. We have investigated P. aeruginosa PA14 biofilm infection over 7 days in an ex vivo pig lung (EVPL) model for CF, previously shown to facilitate formation of a clinically relevant P. aeruginosa biofilm structure with expression of key genes comparable to human infection. We have compared P. aeruginosa gene expression between sequential time points: 24 h, 48 h and 7 days post-infection, and investigated tolerance to polymyxins. Our results demonstrate that the EVPL model can maintain a P. aeruginosa biofilm population, which exhibits increased antibiotic tolerance, for at least 7 days. Differential expression of antimicrobial resistance-associated genes was not observed; however, there was significant upregulation of sulphur metabolism and maintenance of a structured biofilm. Our findings demonstrate that 7 days is a viable time point for studying established, chronic biofilm infection in the EVPL model and provide insight into the accompanying gene expression changes.

## Linked entities

- **Diseases:** cystic fibrosis (MONDO:0009061)
- **Species:** Pseudomonas aeruginosa (taxon 287), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** elastin [NCBI Gene 100620140], LIAS (lipoic acid synthetase) [NCBI Gene 11019] {aka HGCLAS, HUSSY-01, LAS, LIP1, LS, PDHLD}
- **Diseases:** lung infection (MESH:D012141), P. aeruginosa chronic infection (MESH:D011552), biofilm infection (MESH:D007239), AMR (MESH:D060467), CF (MESH:D003550), EVPL (MESH:C536830)
- **Chemicals:** C4-homoserine lactone (-), Sulphur (MESH:D013455), phosphate (MESH:D010710), phenazine (MESH:C000598831), benzoate (MESH:D001565), sulphate (MESH:D013431), oxygen (MESH:D010100), alginate (MESH:D000464), amino acids (MESH:D000596), Nitrogen (MESH:D009584), pyoverdine (MESH:C042453), hexamethyldisilazane (MESH:C024548), Arginine (MESH:D001120), carbon (MESH:D002244), ATP (MESH:D000255), water (MESH:D014867), phospholipids (MESH:D010743), PA14 (MESH:C420063), lipid (MESH:D008055), cysteine (MESH:D003545), iron (MESH:D007501), Bicyclomycin (MESH:C024504), PBS (MESH:D007854), glutaraldehyde (MESH:D005976), glycolipids (MESH:D006017), lipid A (MESH:D008050), Glucose (MESH:D005947), ethanol (MESH:D000431)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Pseudomonas aeruginosa PA14 (strain) [taxon 652611], Pseudomonas aeruginosa (species) [taxon 287], Homo sapiens (human, species) [taxon 9606], Pseudomonas aeruginosa UCBPP-PA14 (strain) [taxon 208963], Sus scrofa (pig, species) [taxon 9823], Pseudomonas aeruginosa PAO1 (strain) [taxon 208964]
- **Cell lines:** PA14 — Homo sapiens (Human), Transformed cell line (CVCL_E800)

## Figures

17 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12962550/full.md

---
Source: https://tomesphere.com/paper/PMC12962550